RxDoctor Payments Data

Paige Tibbs

Acute Care · Huntsville, ALNPI 1922698539

Payments from drug & device makers

$3,755in general payments, 2019–2025

Across 173 payments — averaging $21.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insmed, Inc.$419
  • AstraZeneca$405
  • GSK$370
  • Boehringer Ingelheim$309
  • Sanofi$284
  • Regeneron Healthcare Solutions, Inc.$260
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$3,739100%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,755 in reported general payments places this provider in the 85th percentile of 711 acute care providers in Alabama.

See all acute care providers in Alabama

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter82$64,455
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$10,447
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$9,220
Breo ElliptaFluticasone/Vilanterol20$7,758
Spiriva RespimatTiotropium Bromide14$7,075
Wixela InhubFluticasone Propion/Salmeterol12$4,567
Incruse ElliptaUmeclidinium Bromide11$3,719
Albuterol Sulfate HfaAlbuterol Sulfate158$3,257
Fluticasone-SalmeterolFluticasone Propion/Salmeterol19$2,580
Fluticasone Propionate18$360
Montelukast Sodium23$290
Prednisone31$88

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta$370$85,152133 claims
AstraZenecaBreztri Aerosphere$405$10,44717 claims
Boehringer IngelheimSpiriva Respimat$309$7,07514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 711 acute care providers in Alabama.

Other acute care in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →